CORRELATING DIFFERENTIAL ENDOGENOUS METABOLITE PROFILES WITH THE PHARMACOKINETICS OF GEFITINIB AND ITS ASSOCIATED DRUG METABOLITES USING AN ION MOBILITY BASED APPROACH
Ion Mobility, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Instrumentation
Ion Mobility, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Industries
Pharma & Biopharma